Revenue and taxation; income tax credit; biomanufacturing; effective date.
Summary
HB2366 creates a new Oklahoma income tax credit for certain employees in the biomanufacturing sector. Beginning with tax years after December 31, 2025, a qualified employee may claim a credit of up to $5,000 per year for up to five years over the employee’s lifetime, and the credit may be taken in nonconsecutive years. The bill defines the biomanufacturing sector broadly to include biopharmaceuticals, medical devices, diagnostics, industrial biotechnology, tissue engineering, synthetic biology, related supply and support services, research and development, and education and training for the industry.
To qualify, an employee must work or contract in Oklahoma for a qualified employer whose principal business activity is in biomanufacturing, and must meet education or licensure requirements tied to an accredited engineering program or professional engineer licensure. The bill also includes rules for employees who change employers, allows unused credits to carry forward for five years, and bars the credit from reducing tax liability below zero. The measure is scheduled to take effect November 1, 2025.
Impact
The bill would add a new section to Title 68 of the Oklahoma Statutes, creating Section 2357.305 and expanding the state income tax credit structure. It affects individual income taxpayers employed in biomanufacturing and employers in that sector by creating a targeted tax incentive intended to attract and retain technically trained workers, especially engineers and graduates of ABET-accredited programs. The credit would apply against the tax imposed under Section 2355 of Title 68 and would be subject to carryover and lifetime-use limitations.
Sentiment
Based on the available context, the bill appears to be a pro-growth, workforce-development measure with no recorded committee debate or votes in the provided materials. The absence of opposition or recorded controversy suggests the proposal was, at least at this stage, treated as a specialized economic incentive rather than a broadly contentious tax change. Its framing around advanced manufacturing, engineering talent, and industry development indicates generally favorable policy intent.
Contention
The main points of potential contention are likely to be the targeted nature and fiscal cost of the credit, since it benefits a narrow class of workers and employers rather than taxpayers broadly. Questions could also arise over eligibility definitions, including what counts as biomanufacturing, which employers qualify, and whether the education/licensure requirements are too restrictive or too permissive. Another possible issue is the five-year lifetime cap and the rule allowing nonconsecutive claims, which may affect how the incentive is used and administered.